We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CD2-CD58 Axis: Targets in Immune Synapse, cancer immunotherapy, autoimmune diseases, immune evasion of tumors, antiviral responses, immune rejection
Credit: SinoBiological
Featured Product
Advertisement

CD2-CD58 Axis: Targets in Immune Synapse

CD2-CD58 Axis: Targets in Immune Synapse
Credit: SinoBiological

Recent studies have highlighted the CD2-CD58 axis's relevance in cancer immunotherapy, suggesting its potential to enhance anti-tumor immunity and making it a promising target for therapeutic interventions. The CD2-CD58 axis is associated with the regulation of autoimmune diseases, immune evasion of tumors, antiviral responses, and immune rejection, and targeted therapies for this have been developed. 


Sino Biological offers a wide range of recombinant CD2 and CD58 proteins and antibodies to support elucidating key interactions and pathways and shedding light on potential therapeutic strategies.


About Sino Biological
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.